Loading quotes...
Forecast
The analysts' average price target is €9.61 (+18.64%). The median is €9.61 (+18.64%).
| Buy |
Â
1 |
| Hold |
Â
4 |
| Sell |
Â
0 |
News Go to news feed
Cognyte beats Q2 expectations; shares rise in premarket
Cognyte reported non‑GAAP earnings of $0.15 per share on revenue of $109.2 million for Q2, beating consensus estimates. Stronger growth in the software business (+20.9%) and higher recurring revenue drove margins; the non‑GAAP gross margin increased to 73.7% and adjusted EBITDA climbed to $14.9 million. The company reiterated full‑year targets of roughly $448 million in revenue and $0.47 non‑GAAP EPS and reaffirmed ambitious medium‑term goals, but flagged risks from cash‑flow timing, currency effects and the transition to subscriptions. The stock rose moderately in premarket trading, with market reactions pointing to a positive but cautious investor sentiment. » More on de.investing.com
Cognyte Software up sharply in premarket trading after strong quarterly results and large contracts
Cognyte Software reported revenue of $400 million for fiscal 2026 (+14.1%) and an adjusted EBITDA increase of 65.7%; the operating GAAP result returned to positive territory at $13.3 million. The company recently announced contract renewals and expansions (around $15 million in APAC, around $5 million in EMEA), and analysts rate the stock as "Strong Buy" with a $13.50 price target. In premarket trading the stock climbed about 8.6% to as high as $8.94, supported by positive results, contract demand and analyst optimism. » More on de.investing.com
Cognyte Software receives contract extension worth about $15 million
Cognyte Software reports a contract expansion valued at around $15 million with an existing military intelligence customer in the Asia-Pacific region. The customer is expanding the use of AI‑powered investigative analytics solutions to improve border security, counterterrorism and operational decision‑making. The news triggered a roughly 2.8% increase in the share price. » More on de.investing.com
Financials
| (EUR) | July 2026 | YoY |
|---|---|---|
| Revenue | 94.69m | 10.92% |
| Gross profit | 69.03m | 13.03% |
| Net profit | 3.56m | 176.76% |
| EBITDA | 6.47m | 64.89% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €628.04m |
Number of shares | 73.85m |
52-week high/low | €11.01 - €5.63 |
| Dividends | No |
Beta | 1.59 |
P/E ratio | -2,264.29 |
PEG ratio | 5.37 |
P/B ratio | 3.56 |
P/S ratio | 1.67 |
Company profile
Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions. Its solutions are designed to support various use cases and support a range of users, including data analysts, investigation managers, and security operations center operators, as well as operational field teams. In addition, the company provides customer support, professional, and integration services. Its government customers include national, regional, and local government agencies; and enterprise customers consist of commercial and physical security customers. The company was incorporated in 2020 and is headquartered in Herzliya, Israel.
| Name | Cognyte Software Ltd Ordinary Shares |
| CEO | Elad Sharon |
| Headquarters | Herzliya,
ta USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Technology |
| IPO | 08/02/2021 |
| Employees | 1,710 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | CGNT |
Frankfurt | 81M.F |
MĂĽnchen | 81M.MU |
DĂĽsseldorf | 81M.DU |